ArticleInfection and drug resistance2025
Antimicrobial Resistance Profiles of Bacterial Conjunctivitis Isolates from a Secondary Hospital in Shanghai: A 5-Year Retrospective Study (2020-2024).
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genetic Characterization and Biofilm-Forming Capacity of Bacterial Population Isolated from Conjunctival Samples.Antibiotics (Basel, Switzerland) · 2026Article
- Short peptide 803sp inhibits the inflammatory response induced byFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To analyze the pathogen distribution, epidemiological characteristics, and antimicrobial resistance patterns of bacterial conjunctivitis in a Shanghai secondary hospital from 2020 to 2024, providing evidence for clinical treatment optimization. Patients and Methods: Conjunctival swab specimens from patients clinically diagnosed with bacterial conjunctivitis were collected between January 2020 and December 2024. Bacterial identification and antimicrobial susceptibility testing were performed using the VITEK 2 Compact system and Kirby-Bauer disk diffusion method, respectively. Statistical analyses were conducted using WHONET 5.6 and SPSS 26.0. Results: Among the 611 specimens, 58 bacterial isolates were identified (9.5% positivity rate). Gram-positive cocci predominated (70.7%, 41/58), primarily Conclusion: Gram-positive cocci, particularly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.